Alex Yang
Förmögenhet: 46 M $ per 2026-08-31
Förmögenhet: 46 M $ per 2026-08-31
Alex Yang is currently Chairman & Chief Executive Officer at Polaryx Therapeutics, Inc. since 2023, Chairman & Chief Executive Officer at Epygenix Therapeutics, Inc., and Chief Executive Officer at Mstone Partners Hong Kong Ltd. Formerly, Mr. Yang was Managing Partner at Kim & Chang.
Education includes undergraduate studies at State University of New York at Binghamton and graduate studies at New York University School of Law.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
POLARYX THERAPEUTICS, INC. 45,81 % | 2026-07-27 | 22 833 249 ( 45,81 % ) | 46 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Verkställande Direktör | 2023-03-01 |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Verkställande Direktör | - |
Mstone Partners Hong Kong Ltd. | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
Kim & Chang
Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Kim & Chang
Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Binghamton
State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mstone Partners Hong Kong Ltd. | |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån